Alzamend Neuro (ALZN) Shares Outstanding (Entity) (2020 - 2026)
Alzamend Neuro (ALZN) recorded Shares Outstanding (Entity) of 4.83 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 129.1% from 2.11 million a year earlier and up 44.6% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), Alzamend Neuro reported Shares Outstanding (Entity) of 3.34 million, up 640.3% from FY2025.
- Annual Shares Outstanding (Entity) has increased for six straight fiscal years, with a five-year compound annual growth rate of 131.7% (FY2021 to FY2026).
- Across earlier fiscal years, Shares Outstanding (Entity) came in at 450,799 in FY2025 (+489.7%), 76,444 in FY2024 (+6.5%), 71,807 in FY2023 (+1.5%) and 70,727 in FY2022 (+41.6%).
- The fiscal Q1 2027 figure is the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q4 2020.
- On a year-over-year basis, Shares Outstanding (Entity) has increased for four consecutive quarters, with growth averaging 548.6% over the last seven quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.5% in fiscal Q4 2023 to 868.8% in fiscal Q2 2026.
- Per Business Quant, the preceding three fiscal quarters came in at 3.34 million (Q4 2026), 3.8 million (Q3 2026) and 3.8 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Alzamend Neuro | 8.35 Mn | 8.35 Mn | - | 4.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 4.83 Mn |
| Apr 30, 2026 | 3.34 Mn |
| Jan 31, 2026 | 3.80 Mn |
| Oct 31, 2025 | 3.80 Mn |
| Jul 31, 2025 | 2.11 Mn |
| Apr 30, 2025 | 450,799.00 |
| Jan 31, 2025 | 644,086.00 |
| Oct 31, 2024 | 392,407.00 |
| Jul 31, 2024 | 95,703.00 |
| Apr 30, 2024 | 76,444.00 |
| Jan 31, 2024 | 73,541.00 |
| Oct 31, 2023 | 71,884.00 |
| Jul 31, 2023 | 71,807.00 |
| Apr 30, 2023 | 71,807.00 |
| Jan 31, 2023 | 71,427.00 |
| Oct 31, 2022 | 70,736.00 |
| Jul 31, 2022 | 70,727.00 |
| Apr 30, 2022 | 70,727.00 |
| Jan 31, 2022 | 66,745.00 |
| Oct 31, 2021 | 65,818.00 |
API Access
Alzamend Neuro Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();